JETEMA, Co., Ltd. (KOSDAQ:216080)

South Korea flag South Korea · Delayed Price · Currency is KRW
9,690.00
-410.00 (-4.06%)
At close: Feb 27, 2026
49.54%
Market Cap 352.34B
Revenue (ttm) 75.55B
Net Income (ttm) -4.36B
Shares Out 36.36M
EPS (ttm) -121.79
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 389,691
Average Volume 514,768
Open 10,000.00
Previous Close 10,100.00
Day's Range 9,690.00 - 10,300.00
52-Week Range 5,370.00 - 11,280.00
Beta 1.01
RSI 53.97
Earnings Date Feb 9, 2026

About JETEMA,

JETEMA, Co., Ltd., a bio venture company, engages in the research and development of medicines and medical devices. It offers clostridium botulinum toxins, fillers, lifting threads for medical treatment, elastin and collagen stimulate solution under Ecolla, and healthy skin care under vitten brand names. The company also provides skin care hyaluronic acid masks. JETEMA, Co., Ltd. was founded in 2009 and is headquartered in Wonju-si, South Korea. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2009
Employees 265
Stock Exchange KOSDAQ
Ticker Symbol 216080
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.